333983-03-2

Basic information

• Product Name: (+)-(2R,5R,6R,9R)-4,5-dihydro-5-hydroxy-cis-α-irol acetate
• Synonyms: (+)-(2R,5R,6R,9R)-4,5-dihydro-5-hydroxy-cis-α-irol acetate
• CAS NO: 333983-03-2
• Molecular Weight: 268.397
• Mol File: 333983-03-2.mol

Chemical Properties

• CAS DataBase Reference: (+)-(2R,5R,6R,9R)-4,5-dihydro-5-hydroxy-cis-α-irol acetate(CAS DataBase Reference)
• NIST Chemistry Reference: (+)-(2R,5R,6R,9R)-4,5-dihydro-5-hydroxy-cis-α-irol acetate(333983-03-2)
• EPA Substance Registry System: (+)-(2R,5R,6R,9R)-4,5-dihydro-5-hydroxy-cis-α-irol acetate(333983-03-2)

Safety Data

• Hazardous Substances Data: 333983-03-2(Hazardous Substances Data)

Upstream product

• 108-05-4 vinyl acetate 

Downstream Products

• 307500-68-1 (2R,3E)-4-[(1S,5R)-2,5,6,6-tetramethylcyclohex-2-en-1-yl]but-3-en-2-ol acetate 
• 333982-72-2 (+)-(2R,9R)-β-irol acetate 
• 333983-09-8 (2R,3E)-4-[(1S,3R)-2,2,3-trimethyl-6-methylidenecyclohexyl]but-3-en-2-ol acetate 
• 35124-13-1 (+)-(2R:6S)-cis-α-irone 
• 35124-16-4 (+)-(1'S,3'R,3E)-4-(2',3',3'-trimethyl-6'-methylidenecyclohex-1'-yl)but-3-en-2-one 
• 35124-15-3 (+)-(2R)-β-irone 
• 307523-11-1 (2R,3E)-4-[(1S,5R)-2,5,6,6-tetramethylcyclohex-2-en-1-yl]but-3-en-2-ol 

Relevant articles and documents

Enzyme-Mediated Preparation of (+)- and (-)-β-Irone and (+)- and (-)-cis-γ-Irone from Irone alpha

The (-)- and (+)-β-irones ((-)- and (+)-2, resp.), contaminated with ca. 7-9 percent of the (+)- and (-)-trans-α-isomer, respectively, were obtained from racemic α-irone via the 2,6-trans-epoxide (+/-)-4 (Scheme 2). Relevant steps in the sequence were the LiAlH4 reduction of the latter, to provide the diastereoisomeric-4,5-dihydro-5-hydroxy-trans-α-irols (+/-)-6 and (+/-)-7, resolved into the enantiomers by lipase-PS-mediated acetylation with vinyl acetate. The enantiomerically pure allylic acetate esters (+)- and (-)-8 and (+)- and (-)-9, upon treatment with POCl3/pyridine, were converted to the β-irol acetate derivatives (+)- and (-)-10, and (+)- and (-)-11, respectively, eventually providing the desired ketones (+)- and (-)-2 by base hydrolysis and MnO2 oxidation. The 2,6-cis-epoxide (+/-)-5 provided the 4,5-dihydro-4-hydroxy-cis-α-irols (+/-)-13 and (+/-)14 in a 3:1 mixture with the isomeric 5-hydroxy derivatives (+/-)-15 and (+/-)-16 on hydride treatment (Scheme 1). The POCl3/pyridine treatment of the enantiomerically pure allylic acetate esters, obtained by enzymic resolution of (+/-)-13 and (+/-)-14, provided enantiomerically pure cis-α-irol acetate esters, from which ketones (+)- and (-)-22 were prepared (Scheme 4). The same materials were obtained from the (9S) alcohols (+)-13 and (-)-14, treated first with MnO2, then with POCl3/pyridine (Scheme 4). Conversely, the dehydration with POCl3/pyridine of the enantiomerically pure 2,6-cis-5-hydroxy derivatives obtained from (+/-)-15 and (+/-)-16 gave rise to a mixture in which the γ-irol acetates 25a and 25b and 26a and 26b prevailed over the α- and β-isomers (Scheme 5). The (+)- and (-)-cis-γ-irones ((+)- and (-)-3, resp.) were obtained from the latter mixture by a sequence involving as the key step the photochemical isomerization of the α-double bond to the γ-double bond. External panel olfactory evaluation assigned to (+)-β-irone ((+)-2) and to (-)-cis-γ-irone ((-)-3) the strongest character and the possibility to be used as dry-down note.